full study in the link below
The study investigated the effects of wet-cupping therapy (hijama) on Hashimoto’s disease (HD), an autoimmune thyroid condition characterized by elevated thyroid antibodies and inflammation. Here's a summary and interpretation of the study's findings:
Study Design and Methods:
Participants: The study included 13 adult female HD patients who underwent 3 sessions of hijama over a 6-week period, with a 6-month follow-up.
Intervention: Hijama involved creating skin incisions and applying suction cups at specific anatomical points targeting immune-modulating areas.
Outcomes: Blood tests measured thyroid antibodies (TPO, TG), thyroid hormones (TSH, T4), prolactin, and inflammatory markers (ESR). Clinical assessments included symptom improvement and ultrasound evaluation of thyroid gland characteristics.
Results:
Thyroid Antibodies: The hijama group showed a significant decrease in anti-TPO and anti-TG antibodies compared to the control group, which demonstrated an increase.
Thyroid Hormones: Despite a fixed dose of L-thyroxine, TSH levels decreased significantly in the hijama group, suggesting improved thyroid function.
Inflammatory Markers: ESR and prolactin levels decreased significantly in the hijama group, indicating reduced inflammation.
Ultrasound and Clinical Improvement: Ultrasound assessments revealed improvements in thyroid gland size, vascularity, and clinical symptoms such as constipation, energy levels, and sleep quality.
Interpretation:
Mechanism: The study proposes that hijama may exert its effects by clearing inflammatory mediators and immune complexes, improving tissue vasculature, and potentially modulating immune responses.
Clinical Significance: The findings suggest that hijama could be a beneficial adjunct therapy for HD, potentially slowing autoimmune processes, improving thyroid gland function, and enhancing patient well-being.
Study Limitations: These include a small sample size, absence of a double-blind design, and potential confounders like disease stage and duration.
Conclusion:
Implications: Despite limitations, the study offers promising preliminary evidence supporting hijama as a complementary therapy for managing HD. Further well-designed trials with larger sample sizes are needed to confirm these findings and elucidate underlying mechanisms.
Clinical Practice: Integrating hijama alongside conventional treatments may offer a holistic approach to managing autoimmune thyroid disorders, potentially improving patient outcomes and quality of life.
In summary, while the study highlights potential benefits of hijama in HD management, more robust research is essential to validate these findings and explore its full therapeutic potential in autoimmune diseases.
Comments